Evidence map›Paper›PMID 35702979›Full record

ReviewJournal of materials chemistry. B2022

Carbohydrate based biomaterials for neural interface applications.

Vaishnavi Dhawan, Xinyan Tracy Cui

Abstract readReview
In one paragraph

Review in Journal of materials chemistry. B, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Polysaccharide-based hydrogels for cartilage regeneration.Frontiers in cell and developmental biology · 2024
    Review
  3. Article
  4. Review
  5. Flexible IrOActa biomaterialia · 2023
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vaishnavi DhawanDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA. xic11@pitt.edu.ORCID 0000-0002-4710-2392
Xinyan Tracy CuiDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA. xic11@pitt.edu.ORCID 0000-0002-0470-2005

Funding

Improving chronic neural recording performance through biomaterial strategiesR01NS062019 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CUI, XINYAN TRACY · 2008 to 2018
$4.4M
Inhibition of Neural Electrode-mediated Inflammation and Neuronal Cell DeathR01NS089688 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CUI, XINYAN TRACY · 2015 to 2019
$3.1M
Optimization and Delivery of Bioactive Coating for High Yield and Stable Neural RecordingU01NS113279 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CUI, XINYAN TRACY · 2019 to 2022
$2.4M
Bioengineering in Psychiatry Training ProgramT32MH119168 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, IBRAHIM, TAMER S · 2019 to 2023
$1.1M
NIMH NIH HHS T32 MH119168NINDS NIH HHS R01 NS062019NINDS NIH HHS R01 NS089688NINDS NIH HHS U01 NS113279
6 · The paper itself

Abstract

Neuroprosthetic devices that record and modulate neural activities have demonstrated immense potential for bypassing or restoring lost neurological functions due to neural injuries and disorders. However, implantable electrical devices interfacing with brain tissue are susceptible to a series of inflammatory tissue responses along with mechanical or electrical failures which can affect the device performance over time. Several biomaterial strategies have been implemented to improve device-tissue integration for high quality and stable performance. Ranging from developing smaller, softer, and more flexible electrode designs to introducing bioactive coatings and drug-eluting layers on the electrode surface, such strategies have shown different degrees of success but with limitations. With their hydrophilic properties and specific bioactivities, carbohydrates offer a potential solution for addressing some of the limitations of the existing biomolecular approaches. In this review, we summarize the role of polysaccharides in the central nervous system, with a primary focus on glycoproteins and proteoglycans, to shed light on their untapped potential as biomaterials for neural implants. Utilization of glycosaminoglycans for neural interface and tissue regeneration applications is comprehensively reviewed to provide the current state of carbohydrate-based biomaterials for neural implants. Finally, we will discuss the challenges and opportunities of applying carbohydrate-based biomaterials for neural tissue interfaces.

Indexed as

Biocompatible MaterialsProstheses and ImplantsBrainCarbohydratesElectrodesBiocompatible MaterialsCarbohydrates

Identifiers

PMID35702979
PMCPMC10241218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.